Dr. Mager is Professor and Chair of Pharmaceutical Sciences at the University at Buffalo, State University of New York. He is also President and CEO of Enhanced Pharmacodynamics, LLC. He is a Fellow and Past President of both ACCP and ISoP. He is also a Fellow of AAPS, AAAS, and FIP, of which he serves as Acting Vice President via the Board of Pharmaceutical Sciences. He is also a member of the Scientific Advisory Board to Simcyp. His current research efforts seek to combine network-based analysis with empirical and systems models to explore combinatorial anti-cancer drug regimens, heterogeneity in cancer responses, and chemotherapy-induced adverse drug reactions. He served as a Co-Editor of Systems Pharmacology and Pharmacodynamics and has contributed to 170+ peer-reviewed publications.